Pharmaceutical emulsions: A new approach for gene therapy

Journal of Drug Targeting

Volumn 18, Issue 5, 2010, Pages 333-342

  Verissimo, Lourena Mafra ^a   Agnez Lima, Lucymara Fassarela ^a   Monte Egito, Lucila Carmem ^a   De Oliveira, Anselmo Gomes ^b   Do Egito, E Scrates Tabosa ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Carrier systems; Cationic emulsions; Delivery systems; Gene therapy; Gene transfection

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 2,3 BIS(OLEYL)OXIPROPYLTRIMETHYLAMMONIUM CHLORIDE; 3B [N (N9,N9 DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; ADENOSINE DEAMINASE; CATIONIC SURFACTANT; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; RETROVIRUS VECTOR; SPHINGOMYELIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADSORPTION; BINDING AFFINITY; BIOCOMPATIBILITY; CELL POPULATION; CYTOTOXICITY; DRUG FORMULATION; ELECTROPORATION; EMULSION; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE INSERTION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDRODYNAMICS; HYDROPHILICITY; IMMUNOGENICITY; NANOTECHNOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; THERMODYNAMICS;

EMULSIONS; GENE THERAPY; GENETIC VECTORS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 77952151743     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903434019     Document Type: Review

References (93)

1. Aboofazeli R, Lawrence MJ. (1993). Investigations into the formation and characterization of phospholipid microemulsions.1. Pseudo-ternary phase-diagrams of systems containing waterlecithin-alcohol-isopropyl myristate. Int J Pharm, 93(1-3): 161-175.
2. Ardoin N, Astruc D. (1995). Molecular trees-from syntheses towards applications. Bull De La Societe Chim De France, 132(9): 875-909.
3. Armelini MG, Muotri AR, Marchetto MCN, de Lima-Bessa KM, Sarasin A, Menck CFM. (2005). Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus. Cancer Gene Ther, 12(4): 389-396.
4. Araujo IB, Damasceno BPGL, Medeiros TMD, Soares LAL, Egito EST. (2005). Decrease in Fungizone toxicity induced by the use of Lipofundin as a dilutent: an in vitro study. Curr Drug Deliv, 2(2): 199-205.
5. Barut KD, Coskun Ari FF, Oner F. (2005). Development and characterization of a cationic emulsion formulation as a potential pDNA carrier system. Turkish J Chem, 29: 27-40.
6. Becher P. (1965). Emulsions, Theory and Practice. New York: Reinhold.
7. Berns A. (2004). Good news for gene therapy. N Engl J Med, 350: 1679-1680.
8. Bessis N, Garcia-Cozar FJ, Boissier MC. (2004). Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther, 11 (Suppl 1): S10-S17.
9. Bombelli C, Faggioli F, Luciani P, Mancini G, Sacco MG. (2007). PEGylated lipoplexes: preparation protocols affecting DNA condensation and cell transfection efficiency. J Med Chem, 50: 6274-6278.
10. Brown MD, Schätzlein AG, Uchegbu IF. (2001). Gene delivery with synthetic (non viral) carriers. Int J Pharm, 229(1-2): 1-21.
11. Brunetti-Pierri N, Lee B. (2005). Gene therapy for inborn errors of liver metabolism. Mol Genet Metab, 86(1-2): 13-24.
12. Burand JP, Summers MD, Smith GE. (1980). Transfection with baculovirus DNA. Virology, 101(1): 286-290.
13. Buyens K, Demeester J, De Smedt SS, Sanders NN. (2009). Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes. Langmuir, 25(9): 4886-4891.
14. Callow P, Fragneto G, Cubitt R, Barlow DJ, Lawrence MJ. (2009). Interaction of cationic lipid/DNA complexes with model membranes as determined by neutron reflectivity. Langmuir, 25(7): 4181-4189.
15. Cohen RN, van der Aa M, Macaraeg N, Lee AP, Szoka FC. (2009). Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection. J Control Release, 135(2): 166-174.
16. Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev, 60(6): 757-767.
17. Cross D, Burmester JK. (2006). Gene therapy for cancer treatment: past, present and future. Clin Med Res, 4(3): 218-227.
18. Crystal RG. (1995). Transfer of genes to humans: early lessons and obstacles to success. Science, 270(5235): 404-410.
19. Dias R, Antunes F, Miguel M, Lindman S, Lindman B. (2002). DNAlipid systems. A physical chemistry study. Braz J Med Biol Res, 35(5): 509-522.
20. Dias RS, Pais A, Miguel MG, Lindman B. (2004). DNA and surfactants in bulk and at interfaces. Colloids Surf A-Physicochem Eng Aspects, 250(1-3): 115-131.
21. Egito EST, Araújo IB, Damasceno BPGL, Price JC. (2002). Amphotericin B/emulsion admixture interactions: An approach concerning the reduction of amphotericin B toxicity. J Pharm Sci, 91(11): 2354-2366.
22. Egito EST, Fessi H, Appel M, Barratt G, Legrand P, Bolard J, Devissaguet JP. (1996). A morphological study of an amphotericin B emulsion-based delivery system. Int J Pharm, 145(1-2): 17-27. (Pubitemid 27062982)
23. Egito EST, Fessi H, Appel M, Puisieux F, Bolard J, Devissaguet JP. (1994). New techniques for preparing submicronic emulsions-application to Amphotericin-B. STP Pharma Sci, 4(2): 155-162.
24. Finkelstein MC, Weissmann G. (1979). Enzyme replacement via liposomes. Variations in lipid compositions determine liposomal integrity in biological fluids. Biochim Biophys Acta, 587(2): 202-216.
25. Formiga FR, Fonseca IAA, Souza KB, Silva AKA, Macedo JPF, Araújo IB, Soares LAL, Egito EST. (2007). Influence of a lipophilic drug on the stability of emulsions: An important approach on the development of lipidic carriers. Int J Pharm, 344(1-2): 158-160.
26. Friedmann T. (1990). The evolving concept of gene therapy. Hum Gene Ther, 1(2): 175-181.
27. Friedmann T. (1992). A brief history of gene therapy. Nat Genet, 2(2): 93-98.
28. Glorioso JC, De-Luca NA, Fink DJ. (1995). Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol, 49: 675-710.
29. Guillot-Nieckowski M, Eisler S, Diederich F. (2007). Dendritic vectors for gene transfection. New J Chem, 31(7): 1111-1127.
30. Haensler J, Szoka FC. (1993). Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem, 4(5): 372-379
31. Hara T, Liu F, Liu DX, Huang L. (1997). Emulsion formulations as a vector for gene delivery in vitro and in vivo. Adv Drug Deliv Rev, 24(2-3): 265-271.
32. Hashida M, Kawakami S, Yamashita F. (2005). Lipid carrier systems for targeted drug and gene delivery. Chem Pharm Bull, 53(8): 871-880.
33. Hendrie PC, Russell DW. (2005). Gene targeting with viral vectors. Mol Ther, 12(1): 9-17.
34. Ho HO, Hsiao CC, Sheu MT. (1996). Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. J Pharm Sci, 85(2): 138-143
35. Höbel S, Aigner A. (2009). Nonviral delivery platform for therapeutic RNAi: pegylated siRNA/cationic liposome complexes for targeting of the proto-oncogene bcl-2. Future Oncol, 5(1): 13-17.
36. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, Orr BG, Baker-Jr JR, Holl MM. (2006). Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem. 17(3): 728-734
37. Hung CF, Hwang TL, Chang CC, Fang JY. (2005). Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers. Int J Pharm, 289(1-2): 197-208.
38. Ito A, Takahashi T, Kameyama Y, Kawabe Y, Kamihira M. (2009). Magnetic concentration of a retroviral vector using magnetite cationic liposomes. Tissue Eng Part C Methods, 15(1): 57-64.
39. Kawakami S, Yamashita F, Hashida M. (2000). Disposition characteristics of emulsions and incorporated drugs after systemic or local injection. Adv Drug Deliv Rev, 45(1): 77-88.
40. Kim TW, Chung H, Kwon IC, Sung HC, Jeong SY. (2001). Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents. Pharm Res, 18(1): 54-60.
41. Kim TW, Chung H, Kwon IC, Sung HC, Shin BC, Jeong SY. (2005). Airway gene transfer using cationic emulsion as a mucosal gene carrier. J Gene Med, 7(6): 749-758.
42. Kim TW, Kim YJ, Chung H, Kwon IC, Sung HC, Jeong SY. (2002). The role of non-ionic surfactants on cationic lipid mediated gene transfer. J Control Release, 82(2-3): 455-465.
43. Kwon SM, Nam HY, Nam T, Park K, Lee S, Kim K, Kwon IC, Kim J, Kang D, Park JH, Jeong SY. (2008). In vivo time-dependent gene expression of cationic lipid-based emulsion as a stable and biocompatible non-viral gene carrier. J Control Release, 128(1): 89-97.
44. Lentacker I, Vandenbroucke RE, Lucas B, Demeester J, De Smedt SC, Sanders NN. (2008). New strategies for nucleic acid delivery to conquer cellular and nuclear membranes. J Control Release, 132(3): 279-288.
45. Li W, Szoka FC. (2007). Lipid-based nanoparticles for nucleic acid delivery. Pharm Res, 24(3): 438-449
46. Liu F, Yang J, Huang L, Liu D. (1996). Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsionmediated gene transfer. Pharm Res, 13(11): 1642-1646.
47. Lonez C, Vandenbranden M, Ruysschaert JM. (2008). Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res, 47(5): 340-347.
48. Lv HT, Zhang SB, Wang B, Cui SH, Yan J. (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release, 114(1): 100-109.
49. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. (2000). Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release, 65(1-2): 133-148.
50. Martini E, Fattal E, de Oliveira MC, Teixeira H. (2008). Effect of cationic lipid composition on properties of oligonucleotide/emulsion complexes: Physico-chemical and release studies. Int J Pharm, 352(1-2): 280-286.
51. Marty R, N'soukpoé-Kossi CN, Charbonneau D, Weinert CM, Kreplak L, Tajmir-Riahi HA. (2009). Structural analysis of DNA complexation with cationic lipids. Nucleic Acids Res, 37(3): 849-857.
52. Masotti A, Mossa G, Cametti C, Ortaggi G, Bianco A, Del-Grosso N, Malizia D, Esposito C. (2009). Comparison of different commercially available cationic liposome-DNA lipoplexes: Parameters influencing toxicity and transfection efficiency. Colloids and Surf B-Biointerfaces, 68(2):136-144
53. Masotti A, Ortaggi G. (2009). Chitosan micro-and nanospheres: fabrication and applications for drug and DNA delivery. Mini Rev Med Chem, 9(4): 463-469.
54. Miguel MG, Pais A, Dias RS, Leal C, Rosa M, Lindman B. (2003). DNAcationic amphiphile interactions. Colloids Surf A-Physicochem Eng Aspects, 228(1-3): 43-55.
55. Montier T, Benvegnu T, Jaffrès PA, Yaouanc JJ, Lehn P. (2008). Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr Gene Ther, 8(5): 296-312.
56. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29(21-25): 3477-3496.
57. Nam HY, Park JH, Kim K, Kwon IC, Jeong SY. (2009). Lipid-based emulsion system as non-viral gene carriers. Arch Pharm Res, 32(5): 639-646.
58. Namdeo M, Saxena S, Tankhiwale R, Bajpai M, Mohan YM, Bajpai SK. (2008). Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechnol, 8(7): 3247-3271.
59. Nienhuis A. (2008). The growing clinical impact of gene therapy. Mol Ther, 16(6): 995-996.
60. Niidome T, Huang L. (2002). Gene therapy progress and prospects: nonviral vectors. Gene Ther, 9(24): 1647-1652.
61. Raper SE. (2005). Gene therapy: the good, the bad, and the ugly. Surgery, 137(5): 487-492.
62. Rawat M, Singh D, Saraf S, Saraf S. (2008). Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi, 128(2): 269-280.
63. Rivest V, Phivilay A, Julien C, Bélanger S, Tremblay C, Emond V, Calon F. (2007). Novel liposomal formulation for targeted gene delivery. Pharm Res, 24: 981-990.
64. Roth DA, Tawa-Jr NE, O'Brien JM, Treco DA, Selden RF, Factor VIII Transkaryotic Therapy Study Group. (2001). Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Eng J Med, 344(23):1735-1742
65. Roy I, Stachowiak MK, Bergey EJ. (2008). Nonviral gene transfection nanoparticles: function and applications in the brain. Nanomedicine, 4(2): 89-97.
66. Schatzlein AG. (2001). Non-viral vectors in cancer gene therapy: principles and progress. Anti-cancer Drugs, 12(4): 275-304.
67. Senior J, Gregoriadis G. (1982). Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci, 30(24): 2123-2136.
68. Sokolova V, Epple M. (2008). Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed Engl, 47(8): 1382-1395.
69. Sonoke S, Ueda T, Fujiwara K, Sato Y, Takagaki K, Hirabayashi K, Ohgi T, Yano J. (2008). Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes. Cancer Res, 68(21): 8843-8851.
70. Srinivasachari S, Fichter KM, Reineke TM. (2008). Polycationic beta-cyclodextrin "click clusters": monodisperse and versatile scaffolds for nucleic acid delivery. J Am Chem Soc, 130(14): 4618-4627.
71. Staal FJ, Pike-Overzet K, Ng YY, van Dongen JJ. (2008). Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage? Leukemia, 22(10): 1849-1852.
72. Suri SS, Fenniri H, Singh B. (2007). Nanotechnology-based drug delivery systems. J Occup Med Toxicol, 2: 16.
73. Takino T, Konishi K, Takakura Y, Hashida M. (1994). Long circulating emulsion carrier systems for highly lipophilic drugs. Biol Pharm Bull, 17(1): 121-125.
74. Takino T, Nagahama E, Sakaeda T, Yamashita F, Takakura Y, Hashida M. (1995). Pharmacokinetic disposition analysis of lipophilic drugs injected with various lipid carriers in the singlepass rat-liver perfusion system. Int J Pharm, 114(1): 43-54.
75. Tang MX, Redemann CT, Szoka FC. (1996). In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem, 7(6): 703-714.
76. Templeton NS. (2002). Liposomal delivery of nucleic acids in vivo. DNA Cell Biol, 21(12): 857-867.
77. Thierry AR, Norris V, Molina F, Schmutz M. (2009). Lipoplex nanostructures reveal a general self-organization of nucleic acids. Biochim Biophys Acta, 1790(5): 385-394.
78. Thierry AR, Rabinovich P, Peng B, Mahan LC, Bryant JL, Gallo RC. (1997). Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther, 4(3): 226-237.
79. Tripathy SK, Black HB, Goldwasser E, Leiden JM. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med, 2(5): 545-550.
80. Verma IM, Gage FH. (2000). Genome and gene therapy. Mol Ther, 2(2): 95.
81. Verma IM, Weitzman MD. (2005). Gene therapy: twenty-first century medicine. Annu Rev Biochem, 74: 711-738.
82. Verma IM. (2000). Gene therapy: beyond 2000. Mol Ther, 1(6): 493.
83. Verma IM. (2000). Gene therapy: the need for basic science. Mol Ther, 2(6): 531.
84. Wagner E. (2008). Converging paths of viral and non-viral vector engineering. Mol Ther, 16(1): 1-2.
85. Walters L. (1991). Human gene therapy: ethics and public policy. Hum Gene Ther, 2(2): 115-122.
86. Watanabe T, Umehara T, Yasui F, Nakagawa S, Yano J, Ohgi T, Sonoke S, Satoh K, Inoue K, Yoshiba M, Kohara M. (2007). Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. J Hepatol, 47(6): 744-750.
87. Wolff JA, Rozema DB. (2008). Breaking the bonds: non-viral vectors become chemically dynamic. Mol Ther, 16(1): 8-15.
88. Yi SW, Yune TY, Kim TW, Chung H, Choi YW, Kwon IC, Lee EB, Jeong SY. (2000). A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharm Res, 17(3): 314-320.
89. Zabner J. (1997). Cationic lipids used in gene transfer. Adv Drug Deliv Rev, 27 (1): 17-28.
90. Zelphati O, Uyechi LS, Barron LG, Szoka FC. (1998). Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta, 1390(2): 119-133.
91. Zhang S, Xu Y, Wang B, Qiao W, Liu D, Li Z. (2004). Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release, 100(2): 165-180.
92. Zheng XL, Lu JP, Deng L, Xiong Y, Chen JM. (2009). Preparation and characterization of magnetic cationic liposome in gene delivery. Int J Pharm, 366(1-2): 211-217.
93. Zinder ND, Lederberg J. (1952). Genetic exchange in Salmonella. J Bacteriol, 64(5): 679-699.